Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season

The association of influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was assessed by test‐negative design using data collected for a study of outpatient COVID‐19‐like illness with onset dates from June to September 2020. Multivariable logistic regression mo...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Jennifer P., McLean, Huong Q., Belongia, Edward A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447211/
https://www.ncbi.nlm.nih.gov/pubmed/34169670
http://dx.doi.org/10.1111/irv.12880
_version_ 1784569010722963456
author King, Jennifer P.
McLean, Huong Q.
Belongia, Edward A.
author_facet King, Jennifer P.
McLean, Huong Q.
Belongia, Edward A.
author_sort King, Jennifer P.
collection PubMed
description The association of influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was assessed by test‐negative design using data collected for a study of outpatient COVID‐19‐like illness with onset dates from June to September 2020. Multivariable logistic regression models examined the association between receipt of 2019–2020 influenza vaccine and PCR‐confirmed SARS‐CoV‐2 with adjustment for potential confounders. Receipt of influenza vaccine during the 2019–2020 influenza season was not associated with increased odds of SARS‐CoV‐2 infection in adults (aOR 0.83, 95% CI 0.63 to 1.10) or children (aOR 0.92, 95% CI 0.47 to 1.80).
format Online
Article
Text
id pubmed-8447211
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84472112021-09-17 Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season King, Jennifer P. McLean, Huong Q. Belongia, Edward A. Influenza Other Respir Viruses Short Communications The association of influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was assessed by test‐negative design using data collected for a study of outpatient COVID‐19‐like illness with onset dates from June to September 2020. Multivariable logistic regression models examined the association between receipt of 2019–2020 influenza vaccine and PCR‐confirmed SARS‐CoV‐2 with adjustment for potential confounders. Receipt of influenza vaccine during the 2019–2020 influenza season was not associated with increased odds of SARS‐CoV‐2 infection in adults (aOR 0.83, 95% CI 0.63 to 1.10) or children (aOR 0.92, 95% CI 0.47 to 1.80). John Wiley and Sons Inc. 2021-06-25 2021-11 /pmc/articles/PMC8447211/ /pubmed/34169670 http://dx.doi.org/10.1111/irv.12880 Text en © 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
King, Jennifer P.
McLean, Huong Q.
Belongia, Edward A.
Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
title Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
title_full Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
title_fullStr Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
title_full_unstemmed Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
title_short Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
title_sort risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447211/
https://www.ncbi.nlm.nih.gov/pubmed/34169670
http://dx.doi.org/10.1111/irv.12880
work_keys_str_mv AT kingjenniferp riskofsymptomaticsevereacuterespiratorysyndromecoronavirus2infectionnotassociatedwithinfluenzavaccinationinthe20192020season
AT mcleanhuongq riskofsymptomaticsevereacuterespiratorysyndromecoronavirus2infectionnotassociatedwithinfluenzavaccinationinthe20192020season
AT belongiaedwarda riskofsymptomaticsevereacuterespiratorysyndromecoronavirus2infectionnotassociatedwithinfluenzavaccinationinthe20192020season

Ejemplares similares